Revenue expanded from $682.3M in 2025Q1 to $953.0M in 2026Q3 with gross margin recovering to 23.8%, but operating margin of 13.9% and net margin of 10.7% have not yet shown consistent operating leverage over the period.
BWX Technologies, Inc. (BWXT) annual income statement — 18-year revenue, gross profit & net income history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 |
|---|
| Sales/Revenue | 3.6B | 3.2B | 2.7B | 2.5B | 2.23B | 2.12B | 2.12B | 1.89B | 1.8B | 1.69B | 1.55B | 1.42B | 1.45B | 1.55B | 3.29B | 2.95B | 2.69B | 2.85B | 3.4B |
| Revenue Growth % | 17.74% | 18.3% | 8.31% | 11.8% | 5.12% | 0.03% | 12.06% | 5.28% | 6.64% | 8.85% | 9.54% | -2.42% | -6.21% | -53.01% | 11.49% | 9.79% | -5.81% | -16% | - |
| Cost of Goods Sold | 2.79B | 2.47B | 2.05B | 1.88B | 1.68B | 1.57B | 1.55B | 1.36B | 1.3B | 1.17B | 1.07B | 1.03B | 2.41B | 2.3B | 2.46B | 2.28B | 2.02B | 2.24B | 2.68B |
| COGS % of Revenue | - | 77.13% | 75.77% | 75.14% | 75.28% | 74.09% | 72.9% | 71.83% | 72% | 69.37% | 69.3% | 72.58% | 166.09% | 148.81% | 74.78% | 77.17% | 75.28% | 78.31% | 78.8% |
| Gross Profit | 813.32M | 731.52M | 655.21M | 620.59M | 551.93M | 550.28M | 575.4M | 533.86M | 504.01M | 516.88M | 476.04M | 388.09M | 513.64M | 967.56M | 830.15M | 673.83M | 664.78M | 619.25M | 720.64M |
| Gross Margin % | 22.58% | 22.87% | 24.23% | 24.86% | 24.72% | 25.91% | 27.1% | 28.17% | 28% | 30.63% | 30.7% | 27.42% | 35.41% | 62.56% | 25.22% | 22.83% | 24.72% | 21.69% | 21.2% |
| Gross Profit Growth % | - | 11.65% | 5.58% | 12.44% | 0.3% | -4.37% | 7.78% | 5.92% | -2.49% | 8.58% | 22.66% | -24.44% | -46.91% | 16.55% | 23.2% | 1.36% | 7.35% | -14.07% | - |
| Operating Expenses | 434.12M | 408.28M | 274.6M | 237.53M | 203.36M | 204.43M | 216.84M | 208.34M | 199.04M | 203.53M | 229.81M | 182.15M | 272.45M | 227.36M | 483.56M | 472.21M | 407.61M | 402.94M | 276.16M |
| OpEx % of Revenue | - | 12.77% | 10.16% | 9.52% | 9.11% | 9.62% | 10.21% | 10.99% | 11.06% | 12.06% | 14.82% | 12.87% | 18.78% | 14.7% | 14.69% | 16% | 15.16% | 14.12% | 8.13% |
| Selling, General & Admin | 444.2M | 394.42M | 318.66M | 279.69M | 234.28M | 230.4M | 231.17M | 216.77M | 214.09M | 214.61M | 216.49M | 207.76M | 442.62M | 379.38M | 428.29M | 413.21M | 405.68M | 403.56M | 337.55M |
| SG&A % of Revenue | - | 12.33% | 11.79% | 11.2% | 10.49% | 10.85% | 10.89% | 11.44% | 11.89% | 12.72% | 13.96% | 14.68% | 30.51% | 24.53% | 13.01% | 14% | 15.09% | 14.14% | 9.93% |
| Research & Development | 15.9M | 13.87M | 7.48M | 7.61M | 9.54M | 11.06M | 14.19M | 17.67M | 15.22M | 7.19M | 6.41M | 10.54M | 73.23M | 79.23M | 120.56M | 106.4M | 69.17M | 0 | 0 |
| R&D % of Revenue | - | 0.43% | 0.28% | 0.3% | 0.43% | 0.52% | 0.67% | 0.93% | 0.85% | 0.43% | 0.41% | 0.74% | 5.05% | 5.12% | 3.66% | 3.6% | 2.57% | - | - |
| Other Operating Expenses | -1000K | 0 | -51.54M | -49.77M | -40.45M | -37.03M | -28.51M | -26.1M | -30.28M | -13.81M | 13.89M | -36.15M | -12.68M | -28.55M | -65.29M | -81.74M | -74.04M | -53.87M | -61.4M |
| Operating Income | 379.37M | 323.24M | 380.61M | 383.06M | 348.57M | 345.85M | 358.55M | 325.52M | 304.98M | 292.22M | 234.43M | 205.94M | 25.13M | 306.91M | 346.59M | 95.67M | 248.85M | 269.56M | 444.48M |
| Operating Margin % | 10.53% | 10.11% | 14.08% | 15.35% | 15.61% | 16.28% | 16.88% | 17.18% | 16.94% | 17.31% | 15.12% | 14.55% | 1.73% | 19.84% | 10.53% | 3.24% | 9.26% | 9.44% | 13.08% |
| Operating Income Growth % | - | -15.07% | -0.64% | 9.89% | 0.79% | -3.54% | 10.15% | 6.74% | 4.36% | 24.65% | 13.83% | 719.67% | -91.81% | -11.45% | 262.27% | -61.56% | -7.68% | -39.35% | - |
| EBITDA | 502.81M | 432.43M | 466.47M | 461.63M | 422.41M | 414.93M | 419.23M | 387.24M | 365.07M | 348.78M | 284.98M | 284.56M | 130.92M | 377.44M | 416.29M | 168.67M | 320.49M | 342.28M | 524.2M |
| EBITDA Margin % | 13.96% | 13.52% | 17.25% | 18.49% | 18.92% | 19.53% | 19.74% | 20.44% | 20.28% | 20.67% | 18.38% | 20.1% | 9.03% | 24.4% | 12.65% | 5.71% | 11.92% | 11.99% | 15.42% |
| EBITDA Growth % | 3.56% | -7.3% | 1.05% | 9.28% | 1.8% | -1.03% | 8.26% | 6.07% | 4.67% | 22.39% | 0.15% | 117.35% | -65.31% | -9.33% | 146.8% | -47.37% | -6.37% | -34.71% | - |
| D&A (Non-Cash Add-back) | 123.44M | 109.19M | 85.86M | 78.57M | 73.84M | 69.08M | 60.67M | 61.72M | 60.1M | 56.56M | 50.55M | 78.62M | 105.8M | 70.53M | 69.7M | 73M | 71.63M | 72.71M | 79.72M |
| EBIT | 450.36M | 442.33M | 388.19M | 368.44M | 350.79M | 431.47M | 393.19M | 349.06M | 307.97M | 310.66M | 265.66M | 231.25M | 39.22M | 288.17M | 323.15M | 99.04M | 233.15M | 256.89M | 455.48M |
| Net Interest Income | -10.46M | -40.31M | -36.92M | -44.68M | -35.65M | -35.34M | -30.5M | -34.38M | -25.34M | -13.47M | -7.74M | 20.15M | -6.85M | -2.44M | -2.24M | -3.2M | -11.75M | -21.15M | -7.45M |
| Interest Income | 15.12M | 3.89M | 2.55M | 2.36M | 758K | 416K | 518K | 942K | 2.48M | 1.41M | 651K | 30.33M | 233K | 215K | 1.49M | 1.34M | 1.19M | 3.44M | 15.29M |
| Interest Expense | 25.58M | 44.21M | 39.48M | 47.04M | 36.41M | 35.76M | 31.01M | 35.32M | 27.82M | 14.88M | 8.39M | 10.18M | 7.09M | 2.65M | 3.73M | 4.54M | 12.94M | 24.59M | 22.74M |
| Other Income/Expense | 74.42M | 74.88M | -31.89M | -61.66M | -34.19M | 49.87M | 3.62M | -11.78M | -24.83M | -13.11M | 22.84M | 15.12M | -19.66M | 210.26M | -27.17M | 139.26M | -28.15M | 15.18M | -11.74M |
| Pretax Income | 453.79M | 398.12M | 348.72M | 321.4M | 314.38M | 395.71M | 362.17M | 313.74M | 280.14M | 295.78M | 257.27M | 221.06M | 5.47M | 517.17M | 319.42M | 234.94M | 235.82M | 232.3M | 432.74M |
| Pretax Margin % | 12.6% | 12.45% | 12.9% | 12.88% | 14.08% | 18.63% | 17.06% | 16.56% | 15.56% | 17.53% | 16.59% | 15.62% | 0.38% | 33.44% | 9.7% | 7.96% | 8.77% | 8.14% | 12.73% |
| Income Tax | 77.84M | 68.26M | 66.42M | 75.08M | 75.76M | 89.42M | 82.98M | 69.06M | 52.84M | 147.41M | 73.66M | 80.42M | -15.99M | 184.58M | 101.86M | 72.98M | 82.29M | 84.38M | 108.89M |
| Effective Tax Rate % | 17.15% | 17.15% | 19.05% | 23.36% | 24.1% | 22.6% | 22.91% | 22.01% | 18.86% | 49.84% | 28.63% | 36.38% | -292.55% | 35.69% | 31.89% | 31.06% | 34.9% | 36.32% | 25.16% |
| Net Income | 374.9M | 329.86M | 281.94M | 245.85M | 238.19M | 305.87M | 278.67M | 244.12M | 226.96M | 147.84M | 183.06M | 131.47M | 29.39M | 346.08M | 227.69M | 169.65M | 153.26M | 147.76M | 323.77M |
| Net Margin % | 10.41% | 10.31% | 10.43% | 9.85% | 10.67% | 14.4% | 13.12% | 12.88% | 12.61% | 8.76% | 11.81% | 9.29% | 2.03% | 22.38% | 6.92% | 5.75% | 5.7% | 5.18% | 9.53% |
| Net Income Growth % | 22.1% | 17% | 14.68% | 3.22% | -22.13% | 9.76% | 14.16% | 7.56% | 53.51% | -19.24% | 39.24% | 347.34% | -91.51% | 51.99% | 34.21% | 10.7% | 3.72% | -54.36% | - |
| Net Income (Continuing) | 375.95M | 329.86M | 282.3M | 246.32M | 238.62M | 306.29M | 279.2M | 244.68M | 227.31M | 148.37M | 183.61M | 140.65M | 30.44M | 184.71M | 217.56M | 161.95M | 153.53M | 147.92M | 323.85M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 147.88M | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | -60K | 525K | -276K | -50K | 45K | 60K | 2K | 6K | 39K | 363K | 392K | 13.92M | 15.5M | 18.25M | 16.48M | 9.18M | 666K | 0 | 0 |
| EPS (Diluted) | 4.08 | 3.59 | 3.07 | 2.68 | 2.60 | 3.24 | 2.91 | 2.55 | 2.27 | 1.47 | 1.76 | 1.22 | 0.27 | 3.07 | 1.91 | 0.66 | 1.19 | 1.26 | 2.76 |
| EPS Growth % | 22.46% | 16.94% | 14.55% | 3.08% | -19.75% | 11.34% | 14.12% | 12.33% | 54.42% | -16.48% | 44.26% | 351.85% | -91.21% | 60.73% | 189.39% | -44.54% | -5.56% | -54.35% | - |
| EPS (Basic) | - | 3.60 | 3.08 | 2.68 | 2.60 | 3.24 | 2.92 | 2.56 | 2.29 | 1.49 | 1.79 | 1.23 | 0.27 | 3.09 | 1.92 | 0.67 | 1.20 | 1.27 | 2.79 |
| Diluted Shares Outstanding | 91.99M | 91.86M | 91.86M | 91.87M | 91.7M | 94.52M | 95.73M | 95.81M | 100.02M | 100.37M | 103.84M | 107.58M | 108.76M | 112.69M | 119.02M | 118.4M | 117.63M | 117.42M | 117.42M |
| Basic Shares Outstanding | 91.73M | 91.57M | 91.57M | 91.62M | 91.45M | 94.28M | 95.46M | 95.38M | 99.06M | 99.33M | 102.47M | 106.7M | 108.48M | 111.9M | 118.42M | 117.56M | 116.26M | 116.07M | 116.07M |
| Dividend Payout Ratio | - | 28.03% | 31.34% | 34.56% | 34.04% | 26.05% | 26.17% | 26.78% | 28.12% | 28.44% | 20.41% | 26.23% | 147.91% | 10.98% | 4.17% | 12.29% | 13.34% | - | - |
Quick answers to the most common questions about buying BWXT stock.
For fiscal year 2025, BWX Technologies, Inc. (BWXT) reported total revenue of $3.20B. This represents a 5.9% decline compared to $3.40B in 2008.
BWX Technologies, Inc. (BWXT) is profitable, generating $329.9M in net income for the fiscal year ending 2025 with a net profit margin of 10.3%.
BWX Technologies, Inc. (BWXT) reported an operating income of $323.2M, resulting in an operating profit margin of 10.1%. This margin reflects the operational efficiency of the business before interest and taxes.
BWX Technologies, Inc. (BWXT) generated $731.5M in gross profit for the year, representing a gross profit margin of 22.9%. This demonstrates the company's core pricing power and production efficiency.
Key Metrics
Top Statement Risk
Government program timing concentration
Metrics are mathematically derived from official filings.
Revenue Growth Reaccelerating Into 2026
Based on reported figures, BWXT's quarterly revenue rose from $682.3M in 2025Q1 to $953.0M in 2026Q3, with year-over-year growth reaccelerating to 10.0% in the latest quarter after a trough near 2.9% in 2024Q4 driven by government program timing.
The sequence of year-over-year growth rates, moving from low single digits in late 2024 to 18.0% and 26.2% in early 2026, suggests the revenue base is inflecting rather than simply recovering from a soft comparison. The latest quarter's deceleration to 10.0% from the prior 18.0% indicates the growth rate may be normalizing, which warrants monitoring to determine whether the naval program throughput is sustainable. Investors should monitor whether volume gains from the Navy reactor cadence, rather than pricing, are driving the trend.
Gross Margin Recovering Toward Prior Peak
According to reported financial statements, BWXT's gross margin expanded from a 21.0% trough in 2025Q4 to 23.8% in 2026Q3, approaching the 24.4% to 25.1% range seen across 2024 and mid-2025 quarters.
The margin recovery suggests improved execution or favorable contract mix on the cost-plus government work, though the cyclical trough in late 2025 indicates meaningful quarterly volatility tied to percentage-of-completion adjustments. The current level remains below the mid-2025 peak, which may indicate that the recent expansion is partly a rebound rather than a structural step-up. Investors should monitor whether the commercial isotope mix can lift margins durably above the mid-20s range.
Operating Leverage Remains Modest
As reported in financial statements, BWXT's operating margin reached 13.9% in 2026Q3 versus 14.2% in 2025Q1, indicating that operating income has not yet consistently outpaced gross profit growth despite the revenue expansion.
Because SG&A has grown in step with revenue, operating income has tracked gross profit rather than compounding faster, which suggests limited incremental overhead leverage at current scale. The operating margin's inconsistency across recent quarters, ranging from 8.1% to 14.4%, implies that the cost base carries meaningful variability. This pattern may indicate that operating leverage will depend on sustained program volume rather than structural efficiency gains.
Net Income Diverges From Operating Trend
Based on EPS-reported figures, BWXT's diluted EPS of $1.11 in 2026Q3 reflects a net margin of 10.7%, while net income fell to $71.5M in 2025Q4 despite revenue of $885.8M, indicating that below-the-line items may be contributing meaningful volatility.
The gap between operating income and net income in several quarters, such as 2025Q1 where net income exceeded operating income, suggests non-operating items or tax effects are influencing reported earnings. Stock-based compensation of $5.0M to $10.2M per quarter is modest relative to net income, so it does not appear to be the primary distortion. Investors should monitor the tax rate and non-operating line items to assess how much of the EPS trajectory reflects underlying operations.
Fixed Cost Base Dominates Structure
Based on reported figures, COGS consumed roughly 76% of revenue in 2026Q3 at $725.8M, while R&D remained negligible at $3.8M and SG&A totaled $117.2M, indicating that production cost control drives the margin profile.
The cost structure is dominated by cost of sales, which is consistent with a high-fixed-cost manufacturing base carrying specialized labor and facilities. The R&D line is very small relative to revenue, which suggests the medical isotope and SMR development spending may be partly capitalized or embedded elsewhere, warranting further investigation. Investors should monitor whether SG&A growth remains proportional to revenue as the company scales commercial initiatives.
Program Timing Could Reverse Growth
Based on reported figures, the sharp swing in quarterly revenue growth from 2.9% to 26.2% within two years suggests the top line is highly sensitive to government program timing, which may not persist if procurement schedules slip.
A bear case would focus on whether the 18.0% and 26.2% growth prints reflect one-time catch-up on percentage-of-completion milestones rather than durable volume expansion. The latest deceleration to 10.0% and the already-declining net income trend in late 2025 could be early signals that the cycle is peaking. Investors should monitor reported backlog conversion and any changes in Columbia-class production cadence before extrapolating current growth rates.